Scotland · NHS Scotland MSAN
Zanamivir (Dectova®) 200mg/20ml solution for infusion vials
MSAN(2025)3 · Level 3 · issued 16 Jan 2025
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| 1. Zanamivir (Dectova®) 200mg/20ml solution for infusion vials are in limited supply until late | Limited supply | late |
| 3. Zanamivir (Relenza®) 5mg inhalation powder blisters with device remain available and can | Available | — |
| 4. All strengths and formulations of oseltamivir remain available. | Available | — |
| Registration for access to the website is available to UK healthcare professionals and | Available | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.